Author
Listed:
- P. Savola
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre
University of Helsinki)
- T. Kelkka
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre
University of Helsinki)
- H. L. Rajala
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre)
- A. Kuuliala
(Bacteriology and Immunology, Medicum, University of Helsinki)
- K. Kuuliala
(Bacteriology and Immunology, Medicum, University of Helsinki)
- S. Eldfors
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- P. Ellonen
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- S. Lagström
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- M. Lepistö
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- T. Hannunen
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- E. I. Andersson
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre)
- R. K. Khajuria
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre)
- T. Jaatinen
(Histocompatibility Testing Laboratory, Finnish Red Cross Blood Service)
- R. Koivuniemi
(University of Helsinki and Helsinki University Hospital)
- H. Repo
(Bacteriology and Immunology, Medicum, University of Helsinki)
- J. Saarela
(Institute for Molecular Medicine Finland (FIMM), University of Helsinki)
- K. Porkka
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre)
- M. Leirisalo-Repo
(University of Helsinki and Helsinki University Hospital)
- S. Mustjoki
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Centre
University of Helsinki)
Abstract
Somatic mutations contribute to tumorigenesis. Although these mutations occur in all proliferating cells, their accumulation under non-malignant conditions, such as in autoimmune disorders, has not been investigated. Here, we show that patients with newly diagnosed rheumatoid arthritis have expanded CD8+ T-cell clones; in 20% (5/25) of patients CD8+ T cells, but not CD4+ T cells, harbour somatic mutations. In healthy controls (n=20), only one mutation is identified in the CD8+ T-cell pool. Mutations exist exclusively in the expanded CD8+ effector-memory subset, persist during follow-up, and are predicted to change protein functions. Some of the mutated genes (SLAMF6, IRF1) have previously been associated with autoimmunity. RNA sequencing of mutation-harbouring cells shows signatures corresponding to cell proliferation. Our data provide evidence of accumulation of somatic mutations in expanded CD8+ T cells, which may have pathogenic significance for RA and other autoimmune diseases.
Suggested Citation
P. Savola & T. Kelkka & H. L. Rajala & A. Kuuliala & K. Kuuliala & S. Eldfors & P. Ellonen & S. Lagström & M. Lepistö & T. Hannunen & E. I. Andersson & R. K. Khajuria & T. Jaatinen & R. Koivuniemi & H, 2017.
"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis,"
Nature Communications, Nature, vol. 8(1), pages 1-14, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15869
DOI: 10.1038/ncomms15869
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Jani Huuhtanen & Dipabarna Bhattacharya & Tapio Lönnberg & Matti Kankainen & Cassandra Kerr & Jason Theodoropoulos & Hanna Rajala & Carmelo Gurnari & Tiina Kasanen & Till Braun & Antonella Teramo & Re, 2022.
"Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia,"
Nature Communications, Nature, vol. 13(1), pages 1-16, December.
- Jae-Seung Moon & Shady Younis & Nitya S. Ramadoss & Radhika Iyer & Khushboo Sheth & Orr Sharpe & Navin L. Rao & Stephane Becart & Julie A. Carman & Eddie A. James & Jane H. Buckner & Kevin D. Deane & , 2023.
"Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15869. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.